# Relates to capping cost sharing for antiviral COVID-19 therapeutics

**Bill ID:** A9662AA
**Session:** 2024
**Sponsor:** David Weprin
**Status:** In Assembly Committee
**PDF:** [A9662AA PDF](https://legislation.nysenate.gov/pdf/bills/2024/A9662AA)

## Summary

Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.

---

## Full Text

S T A T E  O F  N E W  Y O R K
 ________________________________________________________________________
 
  9662--A
 
  I N  A S S E M B L Y
 
  March 27, 2024
  ___________
 
 Introduced by M. of A. WEPRIN -- read once and referred to the Committee
  on  Insurance -- committee discharged, bill amended, ordered reprinted
  as amended and recommitted to said committee
 
 AN ACT to amend the insurance  law  and  the  social  services  law,  in
  relation to capping cost sharing for antiviral COVID-19 therapeutics

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
  Section 1.  Subsection (i) of section 3216 of  the  insurance  law  is
 amended by adding a new paragraph 39 to read as follows:
  (39)  (A)  EVERY  POLICY THAT PROVIDES COVERAGE FOR PRESCRIPTION DRUGS
 SHALL PROVIDE COVERAGE FOR ANTIVIRAL THERAPEUTICS  APPROVED  OR  GRANTED
 EMERGENCY  USE AUTHORIZATION BY THE FOOD AND DRUG ADMINISTRATION FOR THE
 TREATMENT OF COVID-19 WHEN PRESCRIBED BY A LICENSED HEALTH CARE PROVIDER
 LEGALLY AUTHORIZED TO PRESCRIBE UNDER TITLE EIGHT OF THE EDUCATION LAW.
  (B) COVERAGE UNDER THIS PARAGRAPH  SHALL  NOT  BE  SUBJECT  TO  ANNUAL
 DEDUCTIBLES  OR  COINSURANCE,  PROVIDED, HOWEVER, THAT AN INSURED WHO IS
 ELIGIBLE FOR AND ABLE TO OBTAIN PRESCRIBED ANTIVIRAL THERAPEUTICS AT  NO
 COST  OR  REDUCED COST UNDER A MANUFACTURER OR GOVERNMENT PROGRAM MAY BE
 REQUIRED TO USE SUCH PROGRAM BEFORE USING COVERAGE REQUIRED PURSUANT  TO
 THIS PARAGRAPH.
  ยง 2. Subsection (k) of section 3221 of the insurance law is amended by
 adding a new paragraph 23 to read as follows:
  (23)  (A) EVERY GROUP OR BLANKET POLICY DELIVERED OR ISSUED FOR DELIV-
 ERY IN THIS STATE THAT PROVIDES COVERAGE FOR  PRESCRIPTION  DRUGS  SHALL
 PROVIDE COVERAGE FOR ANTIVIRAL THERAPEUTICS APPROVED OR GRANTED EMERGEN-
 CY  USE AUTHORIZATION BY THE FOOD AND DRUG ADMINISTRATION FOR THE TREAT-
 MENT OF COVID-19 WHEN PRESCRIBED BY  A  LICENSED  HEALTH  CARE  PROVIDER
 LEGALLY AUTHORIZED TO PRESCRIBE UNDER TITLE EIGHT OF THE EDUCATION LAW.
  (B)  COVERAGE  UNDER  THIS  PARAGRAPH  SHALL  NOT BE SUBJECT TO ANNUAL
 DEDUCTIBLES OR COINSURANCE, PROVIDED, HOWEVER, THAT AN  INSURED  WHO  IS
 ELIGIBLE  FOR AND ABLE TO OBTAIN PRESCRIBED ANTIVIRAL THERAPEUTICS AT NO
 COST OR REDUCED COST UNDER A MANUFACTURER OR GOVERNMENT PROGRAM  MAY  BE
 REQUIRED  TO USE SUCH PROGRAM BEFORE USING COVERAGE REQUIRED PURSUANT TO
 THIS PARAGRAPH.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
  [ ] is old law to be omitted.
  LBD14144-05-4
 A. 9662--A  2

  ยง 3. Section 4303 of the insurance law is  amended  by  adding  a  new
 subsection (vv) to read as follows:
  (VV)  (1)  EVERY CONTRACT ISSUED BY A MEDICAL EXPENSE INDEMNITY CORPO-
 RATION, A HOSPITAL SERVICE CORPORATION, OR A HEALTH SERVICE  CORPORATION
 THAT PROVIDES COVERAGE FOR PRESCRIPTION DRUGS SHALL PROVIDE COVERAGE FOR
 ANTIVIRAL  THERAPEUTICS  APPROVED OR GRANTED EMERGENCY USE AUTHORIZATION
 BY THE FOOD AND DRUG ADMINISTRATION FOR THE TREATMENT OF  COVID-19  WHEN
 PRESCRIBED  BY  A  LICENSED  HEALTH  CARE PROVIDER LEGALLY AUTHORIZED TO
 PRESCRIBE UNDER TITLE EIGHT OF THE EDUCATION LAW.
  (2) COVERAGE UNDER THIS SUBSECTION SHALL  NOT  BE  SUBJECT  TO  ANNUAL
 DEDUCTIBLES  OR  COINSURANCE,  PROVIDED, HOWEVER, THAT AN INSURED WHO IS
 ELIGIBLE FOR AND ABLE TO OBTAIN PRESCRIBED ANTIVIRAL THERAPEUTICS AT  NO
 COST  OR  REDUCED COST UNDER A MANUFACTURER OR GOVERNMENT PROGRAM MAY BE
 REQUIRED TO USE SUCH PROGRAM BEFORE USING COVERAGE REQUIRED PURSUANT  TO
 THIS SUBSECTION.
  ยง  4. Subdivision 2 of section 365-a of  the  social  services  law is
 amended by adding a new paragraph (nn) to read as follows:
  (NN) (I) ANTIVIRAL THERAPEUTICS  APPROVED  OR  GRANTED  EMERGENCY  USE
 AUTHORIZATION  BY  THE FOOD AND DRUG ADMINISTRATION FOR THE TREATMENT OF
 COVID-19 WHEN PRESCRIBED BY A  LICENSED  HEALTH  CARE  PROVIDER  LEGALLY
 AUTHORIZED TO PRESCRIBE UNDER TITLE EIGHT OF THE EDUCATION LAW.
  (II) COVERAGE UNDER THIS PARAGRAPH SHALL BE PROVIDED AT NO COST TO THE
 INSURED, PROVIDED, HOWEVER, THAT AN INSURED WHO IS ELIGIBLE FOR AND ABLE
 TO  OBTAIN  PRESCRIBED ANTIVIRAL THERAPEUTICS AT NO COST OR REDUCED COST
 UNDER A MANUFACTURER OR GOVERNMENT PROGRAM MAY BE REQUIRED TO  USE  SUCH
 PROGRAM BEFORE USING COVERAGE REQUIRED PURSUANT TO THIS PARAGRAPH.
  ยง  5.  This  act  shall  take  effect on the first day of January next
 succeeding the date on which it shall have become a law and shall  apply
 to  all  policies  and  contracts issued, renewed, modified, altered, or
 amended on or after such date.